Matches in Wikidata for { <http://www.wikidata.org/entity/Q90805737> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- Q90805737 description "article scientifique publié en 2018" @default.
- Q90805737 description "artículu científicu espublizáu en setiembre de 2018" @default.
- Q90805737 description "scientific article published on 01 September 2018" @default.
- Q90805737 description "wetenschappelijk artikel" @default.
- Q90805737 description "наукова стаття, опублікована у вересні 2018" @default.
- Q90805737 name "Efficacy and tolerability of trabectedin in elderly patients with sarcoma: subgroup analysis from a phase III, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma" @default.
- Q90805737 name "Efficacy and tolerability of trabectedin in elderly patients with sarcoma: subgroup analysis from a phase III, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma" @default.
- Q90805737 type Item @default.
- Q90805737 label "Efficacy and tolerability of trabectedin in elderly patients with sarcoma: subgroup analysis from a phase III, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma" @default.
- Q90805737 label "Efficacy and tolerability of trabectedin in elderly patients with sarcoma: subgroup analysis from a phase III, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma" @default.
- Q90805737 prefLabel "Efficacy and tolerability of trabectedin in elderly patients with sarcoma: subgroup analysis from a phase III, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma" @default.
- Q90805737 prefLabel "Efficacy and tolerability of trabectedin in elderly patients with sarcoma: subgroup analysis from a phase III, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma" @default.
- Q90805737 P1433 Q90805737-CE673950-E8A1-48C4-90A0-0CA1A42B53FC @default.
- Q90805737 P1476 Q90805737-2ECC55A0-E59F-4E72-B4DB-532FD42C9F11 @default.
- Q90805737 P2093 Q90805737-16F42F58-D3B4-4294-B358-7EEA155A8E92 @default.
- Q90805737 P2093 Q90805737-256AD9C2-F74C-4EBB-92DC-A9A6E9A5A240 @default.
- Q90805737 P2093 Q90805737-5C1616C5-1093-41D9-BB87-060AE946A6C5 @default.
- Q90805737 P2093 Q90805737-640F289D-619A-4A35-AD66-73033404C466 @default.
- Q90805737 P2093 Q90805737-67DD1C19-B0C4-4EFF-895E-8DFCC5DC6EF9 @default.
- Q90805737 P2093 Q90805737-9AD4096B-396B-4C72-97E9-6E6D31BDE5A6 @default.
- Q90805737 P2093 Q90805737-BB83A106-6DC1-4CF3-A39D-B0A602D1D50D @default.
- Q90805737 P2093 Q90805737-C0B75E9E-B899-41B1-8C65-E1AEF2273D5E @default.
- Q90805737 P2093 Q90805737-CA2ED2DA-4F35-47EA-83D1-4553D150B637 @default.
- Q90805737 P2093 Q90805737-D1C04198-518F-4B04-BDA8-B8B2B314FE11 @default.
- Q90805737 P2093 Q90805737-DEF7E8F7-A9CE-4226-9A5A-3AF609C6E2A4 @default.
- Q90805737 P2093 Q90805737-EA922061-E235-439E-8D1F-3C8F21B9C4AB @default.
- Q90805737 P304 Q90805737-6BE2242E-F307-47A2-A2F6-3AED30E0935F @default.
- Q90805737 P31 Q90805737-1B454A9F-3900-4303-902B-AE57BD900A08 @default.
- Q90805737 P356 Q90805737-A6F2910D-CBB9-4419-B4D6-06B87BC0F214 @default.
- Q90805737 P433 Q90805737-D0B61D3B-2999-4317-9E32-DC8FC4A3B204 @default.
- Q90805737 P478 Q90805737-16C1A16C-063A-466A-89EE-10F488F504C2 @default.
- Q90805737 P50 Q90805737-166CC94C-9445-4A7E-A075-A3BD3C7D75AD @default.
- Q90805737 P50 Q90805737-26265E86-659D-4327-9A28-7FD1CDF543F6 @default.
- Q90805737 P50 Q90805737-97A64FDA-15EF-41F3-982F-3D9E5345D76B @default.
- Q90805737 P577 Q90805737-389EED54-862D-471E-826A-67AEF8B18EBE @default.
- Q90805737 P698 Q90805737-48F99985-F9C0-4CEF-965F-D55FBBCDD266 @default.
- Q90805737 P921 Q90805737-67F315A0-FFC4-43BA-BCDD-D15F5077868D @default.
- Q90805737 P921 Q90805737-9A2FB517-FDBD-4B9E-8EE4-432F4BD5733F @default.
- Q90805737 P932 Q90805737-1F8AE498-506D-44E8-87E3-B70D38FAD3DF @default.
- Q90805737 P356 MDY253 @default.
- Q90805737 P698 30084934 @default.
- Q90805737 P1433 Q326122 @default.
- Q90805737 P1476 "Efficacy and tolerability of trabectedin in elderly patients with sarcoma: subgroup analysis from a phase III, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma" @default.
- Q90805737 P2093 "A Elias" @default.
- Q90805737 P2093 "B A Van Tine" @default.
- Q90805737 P2093 "G D Demetri" @default.
- Q90805737 P2093 "G Wang" @default.
- Q90805737 P2093 "J Hamm" @default.
- Q90805737 P2093 "M L Hensley" @default.
- Q90805737 P2093 "M von Mehren" @default.
- Q90805737 P2093 "R Knoblauch" @default.
- Q90805737 P2093 "S M Schuetze" @default.
- Q90805737 P2093 "S McCarthy" @default.
- Q90805737 P2093 "S Patel" @default.
- Q90805737 P2093 "T Parekh" @default.
- Q90805737 P304 "1995-2002" @default.
- Q90805737 P31 Q13442814 @default.
- Q90805737 P356 "10.1093/ANNONC/MDY253" @default.
- Q90805737 P433 "9" @default.
- Q90805737 P478 "29" @default.
- Q90805737 P50 Q47451450 @default.
- Q90805737 P50 Q58128908 @default.
- Q90805737 P50 Q84574401 @default.
- Q90805737 P577 "2018-09-01T00:00:00Z" @default.
- Q90805737 P698 "30084934" @default.
- Q90805737 P921 Q1504713 @default.
- Q90805737 P921 Q416975 @default.
- Q90805737 P932 "6454486" @default.